Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
US7285542B2 · kind B2 · utility
0Cited by
11References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 12, 2003 |
| Grant date | Oct 23, 2007 |
| Priority date | — |
| Expiry date | Oct 31, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2840/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions are provided for transgene expression in target cells. Expression constructs using an inducible amplification system to drive expression of a therapeutic gene or other gene of interest in mammalian host cells are provided, as well as methods therefor. Inducible expression of the transgenes at high levels under physiologic conditions results from induction by hyperthermic conditions relative to the basal temperature of the host cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.